Novel cell and gene therapies, innovative drug delivery solutions and digital therapeutics for obesity, diabetes and CHF management to create growth opportunities, finds Frost & Sullivan
SANTA
Growth Capitalist (https://growthcapitalist.com/2018/06/mhealth-for-diabetes-and-heart-failure-will-revolutionize-the-cardiometabolic-market/)
Novel cell and gene therapies, innovative drug delivery solutions and digital therapeutics for obesity, diabetes and CHF management to create growth opportunities, finds Frost & Sullivan
SANTA